TP ICAP Expands Global Reach with Acquisition of Vantage Capital Markets
TP ICAP reaches acquisition agreement to acquire Vantage Capital Markets, aiming to strengthen its position in equity derivatives and fixed income.
简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:Fidelity Global Innovators Fund raises its risk rating to High in 2026 on volatility and outperformance, with Series F posting 23.3% annualized since 2017.

Fidelity Investments Canada will raise the risk rating for Fidelity Global Innovators Fund and Fidelity Global Innovators Investment Trust from Medium-to-High to High, effective January 9, 2026, citing elevated 10-year volatility and sustained benchmark-beating returns under portfolio manager Mark Schmehl. The fund facts are scheduled to be updated on or around November 10, 2025, to reflect the change under the Canadian Securities Administrators standardized risk classification framework.
| Affected Funds | Fidelity Global Innovators Fund & Investment Trust |
| Old Risk Rating | Medium-to-High |
| New Risk Rating | High |
| Effective Date | January 9, 2026 |
| Fund Facts Update | On or around November 10, 2025 |
As of August 31, 2025, the fund has demonstrated strong performance, outpacing its benchmarks and peers. Morningstar has assigned the fund an overall 5-star rating.
| Fund | Fidelity Global Innovators Class (Series F, net of fees, CAD) |
| Annualized Return Since Inception | 23.3% (from November 1, 2017) |
| Cumulative Return Since Inception | Approximately 417% |
| Peer Ranking | Leads 100% of Global Equity peers over multi-year periods |
The fund has also shown significant excess returns when compared to the NASDAQ Composite Index.
| Year-to-Date | 5.4% |
| 1-Year | 9.0% |
| 2-Year | 14.0% |
| 3-Year | 8.6% |
The risk rating revision follows the CSA‘s standardized methodology based on the 10-year annualized standard deviation of fund returns, a measure that has risen alongside global market turbulence. Over the past decade, swings tied to trade frictions, the COVID-19 shock, inflation pressures, and interest-rate cycles have amplified equity volatility, particularly for innovation-led growth exposures. Despite the higher risk label, Fidelity states there are no changes to the fund’s investment objective, strategy, or portfolio leadership.
The mandate seeks long-term capital appreciation by investing globally in companies with the potential to be disruptive innovators, aligning with investor interest in transformative growth themes. Portfolio manager Mark Schmehl continues to run the strategy with an emphasis on innovation-driven equity selection, aiming to extend a record of long-term outperformance versus benchmarks and peers. Fidelity notes that funds remain available through advisors and online platforms, supported by the firms Canadian business with $320 billion in assets under management as of August 31, 2025.

Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.

TP ICAP reaches acquisition agreement to acquire Vantage Capital Markets, aiming to strengthen its position in equity derivatives and fixed income.

FIBO Group has grabbed attention from traders for mostly the wrong reasons, as traders have accused the broker of causing financial losses using malicious tactics. Whether it is about withdrawal access, deposit disappearance, trade manipulation, or awful customer support service, the broker is receiving flak from traders on all aspects online. Our team accumulated a list of complaints against the FIBO Group broker. Let’s screen these with us in this FIBO Group review article.

Do you have to pay taxes or margin when seeking fund withdrawals from GMO-Z.com, a Thailand-based forex broker? Do you witness heavy slippage when trading on the broker’s platform? These are some complaints traders have made against the broker. In this GMO-Z.com review article, we have explained these complaints. Take a look!

EOBroker Review shows a low WikiFX score of 1.33/10. No regulation, fake license, and unsafe trading make this broker dangerous.